Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 121 - 135 of 175 items.
Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
AlertHealth professional risk communication | 2020-05-06
Importation of US-Labelled Vecuronium Bromide for Injection due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled QUELICIN (succinylcholine chloride injection) due to Shortage of Canadian-labelled QUELICIN
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
AlertHealth professional risk communication | 2020-03-31
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Cybersecurity vulnerabilities associated with some medical devices with Bluetooth Low Energy chips
AlertInformation update | 2020-03-11
GILENYA (fingolimod) - Risk of Congenital Malformations
AlertHealth professional risk communication | 2019-12-19
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
Health Canada clarification: laser-based medical devices are not licensed in Canada to cure fungal nail infections
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02